Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
aminosalicylic acid arachidonate 5-lipoxygenase small molecule NA drugbank Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved inhibitor
aminosalicylic acid inhibitor of nuclear factor kappa-b kinase subunit alpha small molecule NA drugbank Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved inhibitor
aminosalicylic acid dihydrofolate reductase NA Successful target TTD , DGIDB Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved unknown
aminosalicylic acid group iie secretory phospholipase a2 small molecule NA drugbank Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved unknown
aminosalicylic acid prostaglandin g/h synthase 1 NA Successful target TTD , DGIDB Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved unknown
aminosalicylic acid prostaglandin g/h synthase 2 small molecule Successful target TTD , drugbank , DGIDB Tuberculosis[MeSHID:D014376]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammatory Bowel Diseases[MeSHID:D015212]
Lung[MeSHID:D008168]		 NA approved inhibitor
click here to return to the previous page